Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-006932

10% owner bought 3,750 shares at $14.12 ($52,950)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-24 Purchase : show line 1 in the form +3,750 $14.12 $52,950 4,802,544 D
Open-market purchases · 3,750 sh · avg $14.12 · $52,950
Loading xslF345X03/doc1.xml…